Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart

  • 35 Accesses

  • 48 Citations

Abstract

NO has been implicated in the mechanism of ischaemic preconditioning. To verify this hypothesis further we have attempted to reproduce effects of ischaemic preconditioning by nitric oxide donors administration prior to the ischaemia. The effect of glyceryl trinitrate (GTN) and 3-morpholino-sydnonimine-hydrochloride (SIN- 1), NO donors, on reperfusion induced ventricular tachycardia (VT) and ventricular fibrillation (VF) in Langendorff perfused rat hearts subjected to 10 min regional ischaemia followed by 10 min reperfusion were examined. Results: GTN, 500 μM and SIN-1, 10 μM, administered for 5 min and washed for another 5 min prior to ischaemia (to mimic ischaemic preconditioning), almost completely abolished reperfusion induced VF. GTN and SIN-1, administered at the time of reperfusion, increased the incidence of sustained VF and the duration of VT and VF. When given 5 min before the ischaemia and throughout the ischaemia and the reperfusion, SIN-1 abolished VF. Adenosine, 10 μM, applied according to the above three protocols, did not affect reperfusion arrhythmias, although adenosine induced changes in coronary flow and post-ischaemic reflow were similar to those produced by the NO donors. In conclusions: (1) NO is able to mimic the effect of ischaemic preconditioning on reperfusion arrhythmias in rat heart, supporting the view that NO may be one of the endogenous substances triggering ischaemic preconditioning; (2) In crystalloid-perfused heart, NO may be deleterious when its administration is restricted to the reperfusion period.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136 1986

  2. 2.

    Lawson CS, Downey JM: Preconditioning — state of the art myocardial protection. Cardiovasc Res 27: 542–550, 1993

  3. 3.

    Parratt JR: Protection of the heart by ischaemic preconditioning -mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 15: 19–25, 1994

  4. 4.

    Li YW, Kloner RA: The cardioprotective effects of ischemic preconditioning are not mediated by adenosine receptors in rat hearts. Circulation 87: 1642–1648, 1993

  5. 5.

    Cave AC, Collis CS, Downey JM, Hearse DJ: Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovase Res 27: 663–668, 1993

  6. 6.

    Miura T, Ishimoto R, Sakamoto J, Tsuchida A, Suzuki K, Ogawa T, Shimamoto K: Suppression of reperfusion arrhythmia by ischemic preconditioning in the rat: Is it mediated by the adenosine receptor, prostaglandin, or bradykinin receptor? Basic Res Cardiol 90: 240–246, 1995

  7. 7.

    Vegh A, Szekeres L, Parratt JR: Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 107: 648–652, 1998

  8. 8.

    Kopacz M, Karwatowska-Prokopczuk E, Beresewicz A: Reperfusion arrhythmias and purine wash-out in isolated rat and rabbit heart. Effect of allopurinol, dimethylthiourea, and calcium reduction. J Mol Cell Cardiol 25: 859–874, 1993

  9. 9.

    Halpern MH: The dual blood supply of the heart. Am J Anat 101: 116, 1957

  10. 10.

    Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins A, Julian DJ, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russel DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth Conventions. Guide lines for the study of arrhythmias in my ocardial ischemia, infarction and reperfusion. Cardiovasc Res 22: 447–455, 1988

  11. 11.

    Ibuki C, Hearse DJ, Avkiran M: Rate of reflow and reperfusion induced arrhythmias: Studies with dual coronary perfusion. Cardiovasc Res 26: 316–323, 1998

  12. 12.

    Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142, 1991

  13. 13.

    Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116–1121, 1992

  14. 14.

    Shiki K, Hearse DJ: Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 253: H1470-H1476, 1987

  15. 15.

    Hagar JM, Hale SL, Kloner RA: Effects of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in rat. Circ Res 68: 61–68, 1991

  16. 16.

    Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK: Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 23: 365–373, 1994

  17. 17.

    Liu YG, Downey JM: Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G-protein. Cardiovasc Res 27: 608–611, 1993

  18. 18.

    Lawson CS, Coltart DJ, Hearse DJ: The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res 27: 681–687, 1993

  19. 19.

    Speechly-Dick ME, Mocanu MM, Yellon DM: Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 75: 586–590, 1994

  20. 20.

    Li YW, Kloner RA: Does protein kinase C play a role in ischemic preconditioning in rat hearts? Amer J Physiol-Heart Circ Phy 37: H426-H431, 1995

  21. 21.

    Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M: Ventricular overdrive pacing-induced anti-ischemic effect: A conscious rabbit model of preconditioning. Am J Physiol 266: H2033-H2041, 1994

  22. 22.

    Shah AM, Lewis MJ: Modulation of myocardial contraction by endocardial and coronary vascular endothelium. Trend Cardiovasc Med 3: 98–103, 1993

  23. 23.

    Mery PF, Pavoine C, Belhassen L, Pecker F, Fischmeister R: Nitric oxide regulates cardiac Ca2− current: Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268: 26286–26295, 1993

  24. 24.

    Hearse DJ, Tosaki A: Free radicals and calcium: Simultaneously interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in rat heart. J Mol Cell Cardiol 20: 213–223, 1988

  25. 25.

    Kanner J, Harel S, Granit R: Nitric oxide as an antioxidant. Arch Biochem Biophys 289: 130–136, 1991

  26. 26.

    Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A: EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 7: 1124–1134, 1993

  27. 27.

    Fukahori M, Ichimori K, Ishida H, Nakagawa H, Okino H: Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radical Res 21: 203–212, 1994

  28. 28.

    Manning AS, Hearse DJ: Reperfusion-induced arrhythmias: mechanism and prevention. J Mol Cell Cardiol 16: 597–518, 1984

  29. 29.

    Bernier M, Manning AS, Hearse DJ: Reperfusion arrhythmias: Doserelated protection by anti-free radical interventions. Am J Physiol 256: H1344-H1352, 1989

  30. 30.

    Johnson G,III., Tsao PS, Mulloy D, Lefer AM: Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252: 35–41, 1990

  31. 31.

    Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao ZQ, Fowler WC, Mcgee DS, Johnston WE: Intracoronary 1-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263: H1650-H1658, 1992

  32. 32.

    Beckman JS, Beckman TW Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620–1624, 1990

  33. 33.

    Garlick PB, Davis MJ, Hearse DJ, Slater TF: Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61: 757–760, 1987

  34. 34.

    Zweier JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84: 1404–1407, 1987

  35. 35.

    Matheis G, Sherman MP, Buckberg GD, Hayborn DM, Young HH, Ignarro LJ: Role of L-arginine-nitric oxide pathway in myocardial reoxygenetion injury. Am J Physiol 262: H616-H620, 1992

Download references

Author information

Correspondence to Andrzej Beręsewicz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bilińska, M., Mączewski, M. & Beręsewicz, A. Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart. Mol Cell Biochem 160, 265–271 (1996). https://doi.org/10.1007/BF00240058

Download citation

Key words

  • nitric oxide
  • preconditioning
  • reperfusion arrhythmias
  • isolated rat heart
  • SIN-1
  • glyceryl trinitrate
  • adenosine
  • nitric oxide toxicity